Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01962012 · ClinicalTrials.gov registry record · Phase 4

Effect of AcceleDent® Aura on Orthodontic Tooth Movement With Aligners

A Phase 4 study of Malocclusion, sponsored by OrthoAccel Technologies.

Completed
Registry status
Phase 4
Development phase
46
Enrollment target
1
Study location

NCT01962012 is a Phase 4 study of Malocclusion that has completed, run by OrthoAccel Technologies. The registered enrollment target is 46 participants, below the 101-participant average among 6 other Malocclusion trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01962012, a Phase 4 study of Malocclusion, has completed, sponsored by OrthoAccel Technologies.

COMPLETED
Registry status
Phase 4
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the amount of tooth movement achieved over time between subjects undergoing aligner treatment using a pulsation device known as AcceleDent® Aura with those not using the device.

Conditions Studied

Interventions

  • DEVICE Sham Device
  • DEVICE AcceleDent Aura

Study Locations (1)

Florida

  • University of Florida, Department of Orthodontics - Gainesville

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2013-10
Est. Completion 2016-05
Phase Phase 4

Sponsor

OrthoAccel Technologies

2 total trials

What the Registry Record Tells You About NCT01962012

The ClinicalTrials.gov registry entry for NCT01962012 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 101-participant average among 6 other Malocclusion trials with a reported enrollment target (54% lower). The listed sponsor is OrthoAccel Technologies, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Malocclusion appearing as the primary indexed condition, and to 2 interventions - of which Sham Device is the first listed.

NCT01962012 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT01962012 about?

NCT01962012 is a clinical study titled "Effect of AcceleDent® Aura on Orthodontic Tooth Movement With Aligners". The purpose of this study is to examine the amount of tooth movement achieved over time between subjects undergoing aligner treatment using a pulsation device known as AcceleDent® Aura with those not using the device.

What is the current status of trial NCT01962012?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2013-10. Estimated completion is 2016-05.

What conditions does trial NCT01962012 study?

This clinical trial studies the following conditions: Malocclusion.

What interventions are being tested in trial NCT01962012?

The interventions under investigation include: Sham Device (DEVICE), AcceleDent Aura (DEVICE).

Who is sponsoring clinical trial NCT01962012?

This trial is sponsored by OrthoAccel Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01962012 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malocclusion

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.